MIVO® Organ on Chip Platform

Integrated microfluidic platform for organ-on-chip and cell culture applications with biocompatible material options. Supports long-term cell maintenance with precise fluidic control for physiological simulation.

Technology platform for developing and testing microphysiological systems that simulate human organ and tissue behavior in vitro. Enables preclinical drug testing, toxicology assessment, and disease modeling with improved physiological relevance compared to conventional cell cultures. Integrates microfluidics, tissue engineering, and analytical capabilities for pharmaceutical and biomedical research applications.

A comprehensive organoid culture and development platform designed for creating three-dimensional tissue models from patient or donor cells. The system supports the establishment and maintenance of organoid biobanks for research and therapeutic applications.

An integrated organoid-based system for preclinical drug screening and development, enabling pharmaceutical companies to test compound efficacy on relevant tissue models.

Proprietary microfluidics technology platform designed for point-of-care testing and molecular diagnostics applications. Enables precise fluid handling and sample processing in miniaturized formats for rapid diagnostic analysis.

Integrated system for fabricating lab-on-chip devices with precise fluid handling capabilities. Enables miniaturized diagnostic and analytical testing platforms. Supports development of portable diagnostic solutions.

Microfluidic biochip technology for multiplexed biomarker detection and analysis. Supports simultaneous testing of multiple analytes in diagnostic applications.

A microfluidic-based diagnostic platform that enables rapid biochemical testing with minimal sample volumes. The technology integrates sample preparation, reaction, and detection on a single chip for efficient laboratory workflows.

Microfluidic device platform designed for organ tissue modeling and in vitro biological simulation. Incorporates low-autofluorescence materials suitable for continuous monitoring and optical imaging of cellular systems.

Microfluidic-based system enabling isolation, analysis, and characterization of individual cells for research and diagnostic applications. Provides high-resolution cellular analysis and sorting capabilities.

A diagnostic platform utilizing microelectromechanical systems (MEMS) and lab-on-a-chip technology for blood disease diagnosis devices. The platform features optical system components with various wavelength channels, thermal control, fluidic and protocol integration, interface-based diverse testing capabilities, and data connectivity with LIS/BIS systems. It provides 99% accuracy, 2X processing speed, and supports 50+ test items.

A versatile wearable and portable platform technology capable of measuring and monitoring multiple biomarkers including glucose, lactate, hormones, and therapeutic drugs. The system utilises nanolitre droplet technology for continuous autonomous measurement.